Enorama Pharma AB (ERMA) — Tangible Net Worth Ratio
Enorama Pharma AB (ERMA) has a Tangible Net Worth Ratio of 94.9% as of June 2025. This metric is calculated by deducting intangible assets (Skr423.00K) from net assets (Skr8.28 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Enorama Pharma AB short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Enorama Pharma AB Tangible Net Worth Ratio (2014–2024)
This chart shows how Enorama Pharma AB's Tangible Net Worth Ratio has changed across 11 annual periods from 2014 to 2024. As of June 2025, the ratio stands at 94.9%, reflecting net assets of Skr8.28 Million with intangible assets of Skr423.00K SEK. See Enorama Pharma AB liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Enorama Pharma AB (2014–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Enorama Pharma AB from 2014 to 2024, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Enorama Pharma AB market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 92.4% | Skr7.80 Million | Skr592.00K | Skr15.89 Million | ▲ +97.6 pp |
| 2023 | -5.2% | Skr19.54 Million | Skr20.56 Million | Skr34.38 Million | ▼ -30.9 pp |
| 2022 | 25.7% | Skr31.52 Million | Skr23.43 Million | Skr48.72 Million | ▲ +48.8 pp |
| 2021 | -23.2% | Skr21.35 Million | Skr26.30 Million | Skr50.93 Million | ▲ +1298.2 pp |
| 2020 | -1321.3% | Skr1.78 Million | Skr25.26 Million | Skr40.91 Million | ▼ -1101.9 pp |
| 2019 | -219.4% | Skr7.18 Million | Skr22.93 Million | Skr42.58 Million | ▼ -201.3 pp |
| 2018 | -18.2% | Skr17.02 Million | Skr20.11 Million | Skr38.83 Million | ▲ +63.7 pp |
| 2017 | -81.9% | Skr7.36 Million | Skr13.39 Million | Skr15.49 Million | ▼ -75.5 pp |
| 2016 | -6.3% | Skr9.08 Million | Skr9.65 Million | Skr13.63 Million | ▼ -106.3 pp |
| 2015 | 100.0% | Skr6.52 Million | Skr0.00 | Skr9.17 Million | ▲ +1.0 pp |
| 2014 | 99.0% | Skr2.66 Million | Skr26.00K | Skr3.69 Million | — |